Profil
Brian Mangal is currently the Director at Biostatistics & Research Information Systems and the Director-Business & Product Development at XORTX Therapeutics, Inc. He previously worked as the Biostatistics Director at Correvio Pharma Corp.
and as the Director-Business Development at XORTX Pharma Corp.
Postes actifs de Brian Mangal
| Sociétés | Poste | Début |
|---|---|---|
| XORTX THERAPEUTICS INC. | Corporate Officer/Principal | - |
| Biostatistics & Research Information Systems | Director/Board Member | - |
Anciens postes connus de Brian Mangal
| Sociétés | Poste | Fin |
|---|---|---|
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | - |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
| Biostatistics & Research Information Systems | |
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
